Core Scientific, Tranche Stock Performance
| CORZZ Stock | 14.10 0.29 2.02% |
On a scale of 0 to 100, Core Scientific, holds a performance score of 4. The firm shows a Beta (market volatility) of 2.67, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Core Scientific, will likely underperform. Please check Core Scientific,'s sortino ratio, semi variance, rate of daily change, as well as the relationship between the value at risk and kurtosis , to make a quick decision on whether Core Scientific,'s price patterns will revert.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Core Scientific, Tranche are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Core Scientific, showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (2.02) | Five Day Return (9.67) | Year To Date Return 759.6 | Ten Year Return 759.6 | All Time Return 759.6 |
1 | Core Scientific Announces Fiscal Third Quarter 2024 Results - Financial Times | 11/06/2024 |
| Begin Period Cash Flow | 52.2 M |
Core |
Core Scientific, Relative Risk vs. Return Landscape
If you would invest 1,251 in Core Scientific, Tranche on September 23, 2024 and sell it today you would earn a total of 159.00 from holding Core Scientific, Tranche or generate 12.71% return on investment over 90 days. Core Scientific, Tranche is currently producing 0.275% returns and takes up 4.3395% volatility of returns over 90 trading days. Put another way, 38% of traded stocks are less volatile than Core, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Core Scientific, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Core Scientific,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Core Scientific, Tranche, and traders can use it to determine the average amount a Core Scientific,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0634
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CORZZ | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.34 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Core Scientific, is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Core Scientific, by adding it to a well-diversified portfolio.
Core Scientific, Fundamentals Growth
Core Stock prices reflect investors' perceptions of the future prospects and financial health of Core Scientific,, and Core Scientific, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Core Stock performance.
| Return On Asset | 0.0261 | ||||
| Profit Margin | (2.23) % | ||||
| Operating Margin | (0.43) % | ||||
| Revenue | 502.4 M | ||||
| EBITDA | (63.12 M) | ||||
| Net Income | (246.49 M) | ||||
| Total Debt | 865.54 M | ||||
| Book Value Per Share | (2.61) X | ||||
| Cash Flow From Operations | 65.11 M | ||||
| Total Asset | 712.16 M | ||||
| Retained Earnings | (2.42 B) | ||||
| Working Capital | (391.41 M) | ||||
About Core Scientific, Performance
Evaluating Core Scientific,'s performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Core Scientific, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Core Scientific, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (6.82) | (6.48) | |
| Return On Tangible Assets | (0.35) | (0.36) | |
| Return On Capital Employed | 0.04 | 0.04 | |
| Return On Assets | (0.35) | (0.36) | |
| Return On Equity | 0.41 | 0.39 |
Things to note about Core Scientific, Tranche performance evaluation
Checking the ongoing alerts about Core Scientific, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Core Scientific, Tranche help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Core Scientific, had very high historical volatility over the last 90 days | |
| Core Scientific, has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 502.4 M. Net Loss for the year was (246.49 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Core Scientific, has a frail financial position based on the latest SEC disclosures |
- Analyzing Core Scientific,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Core Scientific,'s stock is overvalued or undervalued compared to its peers.
- Examining Core Scientific,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Core Scientific,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Core Scientific,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Core Scientific,'s stock. These opinions can provide insight into Core Scientific,'s potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Core Stock Analysis
When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.